GET /api/v0.1/hansard/entries/849881/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 849881,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/849881/?format=api",
    "text_counter": 186,
    "type": "speech",
    "speaker_name": "Garissa Township, JP",
    "speaker_title": "Hon. Aden Duale",
    "speaker": {
        "id": 15,
        "legal_name": "Aden Bare Duale",
        "slug": "aden-duale"
    },
    "content": "(i) in the proposed amendments to the Pharmacy and Poisons Act, Cap. 244− (a) by deleting the proposed amendments to section 2 and substituting therefor the following new amendments− s. 2 Delete the definition of the term “enrolled pharmaceutical technologist”; and substitute therefor the following new definition− “enrolled pharmaceutical technologist” means a holder of a diploma in pharmacy from a training institution recognised by the Board and whose name appears on the Roll; Delete the definition of the term “Inspector of Drugs” and substitute therefor the following new definition− “inspector of Drugs” means a person who is competitively recruited by the Board as a pharmaceutical inspector and who holds a minimum of a diploma in pharmacy; Delete the definition of the term “pharmaceutical inspector”; Delete the definition of the term “registered pharmacist” and substitute therefor the following new definition− “registered pharmacist” means a holder of a degree in pharmacy from a training institution recognised by the Board and whose name is entered on the register; (ii) Insert the following definitions in proper alphabetical sequence− “clinical trial” means any systematic study on pharmaceutical products in human subjects, whether in patients or other volunteers, in order to discover or verify the effects of, identify any adverse reaction to, investigational products, to study the absorption, distribution, metabolism and excretion of the products with the object of ascertaining their efficacy and safety; “Good Manufacturing Practice” also known as “GMP” means a system for ensuring that products are consistently produced and controlled according to quality standards, and is designed to minimise risks involved in any pharmaceutical production that cannot be eliminated through testing the final product; No.2 of 2017"
}